Awareness, Use and Outlook of Complementary and Alternative Medicine (CAM) Options in an Underserved, Uninsured Minority Cancer Patient Population

Integrative oncology aims to coordinate the delivery of conventional medicine and evidence-supported complementary and alternative medicine (CAM) to patients receiving cancer care. This field developed out of an increased interest in CAM usage among cancer patients. However, CAM use among medically underserved cancer patients remains to be well characterized. We evaluated CAM awareness as well as prevalence and characteristics of CAM use in 170 consecutive, medically underserved cancer patients presenting to a large, academic, inner-city cancer clinic, using a survey tool. Fifty-three participants declined participation and 17 survey results were incomplete. Therefore, 100 survey results were included in the final analysis. There were 65 males and 35 females in the survey with a mean age of 64.2 years. About 98% of the respondents were African American while 2% identified themselves as Hispanic. About 45% of patients had metastatic cancer, 24% had early-stage disease while 31% of patients were not aware of the stage of their cancer. About 55% patients had elementary school or lower level of education while only 16% had a college degree or higher. About 92% of respondents were unemployed. Some knowledge of CAM was reported by 22% of patients, while CAM use was reported in only 16% of patients. Female sex and college degree were significantly associated with CAM use. The most commonly used CAM modality was meditation (56%), followed by herbal remedies (31%), yoga (31%), and acupuncture (12%). Among CAM users, a majority used multiple CAM therapies. All users reported benefit from CAM use. Emotional wellbeing was the most common benefit followed by improvement in treatment related adverse effects, chemotherapy related symptoms, pain, and sleep. Even though the majority of our surveyed patients never used CAM, 90% of non-users were interested in gaining more information about the various CAM options and exploring its use and potential benefits. The majority (70%) wanted their primary oncologist to provide information about CAM options and discuss its safety and potential complementary benefit in management of their cancer and associated symptoms.

[1]  A. DeMichele,et al.  Integrative Therapies During and After Breast Cancer Treatment: ASCO Endorsement of the SIO Clinical Practice Guideline. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  M. Hjermstad,et al.  Depression-A Major Contributor to Poor Quality of Life in Patients With Advanced Cancer. , 2017, Journal of pain and symptom management.

[3]  C. Witt,et al.  A Comprehensive Definition for Integrative Oncology. , 2017, Journal of the National Cancer Institute. Monographs.

[4]  J. Mao,et al.  Growth of Integrative Medicine at Leading Cancer Centers Between 2009 and 2016: A Systematic Analysis of NCI-Designated Comprehensive Cancer Center Websites. , 2017, Journal of the National Cancer Institute. Monographs.

[5]  B. Fellman,et al.  Complementary and Alternative Medicine Use in Minority and Medically Underserved Oncology Patients: Assessment and Implications , 2017, Integrative cancer therapies.

[6]  J. Figueiredo,et al.  Complementary and Integrative Health Practices Among Hispanics Diagnosed with Colorectal Cancer: Utilization and Communication with Physicians , 2016, Journal of alternative and complementary medicine.

[7]  G. Asher,et al.  Complementary and Alternative Medicine Use at a Comprehensive Cancer Center , 2016, Integrative cancer therapies.

[8]  R. Rothman,et al.  Cancer survivors' disclosure of complementary health approaches to physicians: The role of patient‐centered communication , 2015, Cancer.

[9]  M. Doty,et al.  The rise in health care coverage and affordability since health reform took effect: findings from the Commonwealth Fund Biennial Health Insurance Survey, 2014. , 2015, Issue brief.

[10]  B. Oh,et al.  Cancer patient disclosure and patient-doctor communication of complementary and alternative medicine use: a systematic review. , 2012, The oncologist.

[11]  M. Zwahlen,et al.  How Many Cancer Patients Use Complementary and Alternative Medicine , 2012, Integrative cancer therapies.

[12]  J. Armer,et al.  Complementary and alternative medicine use among women with breast cancer: a systematic review. , 2010, Clinical journal of oncology nursing.

[13]  Andrew Penman,et al.  Integrating complementary therapies into mainstream cancer care: which way forward? , 2006, The Medical journal of Australia.

[14]  C. Barry.  The role of evidence in alternative medicine: contrasting biomedical and anthropological approaches. , 2006, Social science & medicine.

[15]  A. Vickers,et al.  High prevalence of complementary and alternative medicine use among cancer patients: implications for research and clinical care. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  M. McGrail,et al.  Disclosure of CAM use to medical practitioners: a review of qualitative and quantitative studies. , 2004, Complementary therapies in medicine.

[17]  M. Markman.  Safety issues in using complementary and alternative medicine. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  T. Peretz,et al.  Determinants of the use of complementary therapies by patients with cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  Christopher E. Smith.  United States , 1985, The Lancet.

[20]  C. Wade,et al.  Socioeconomic factors and women's use of complementary and alternative medicine in four racial/ethnic groups. , 2008, Ethnicity & disease.